Free Trial
LON:SUMM

Summit Therapeutics (SUMM) Share Price, News & Analysis

Summit Therapeutics logo

About Summit Therapeutics Stock (LON:SUMM)

Advanced Chart

Key Stats

Today's Range
N/A
50-Day Range
20.50
20.50
52-Week Range
N/A
Volume
280,318 shs
Average Volume
382,504 shs
Market Capitalization
N/A
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
Consensus Rating
N/A

Company Overview

Receive SUMM Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Summit Therapeutics and its competitors with MarketBeat's FREE daily newsletter.

SUMM Stock News Headlines

3..2..1.. AI 2.0 ignition (don’t sleep on this)
I just put together an urgent new presentation that you need to see right away. In short: I believe we are mere days away from a critical announcement from a key tech leader… One that will officially ignite “AI 2.0” – and potentially send a whole new class of stocks soaring.
See More Headlines

SUMM Stock Analysis - Frequently Asked Questions

Summit Therapeutics PLC (LON:SUMM) issued its quarterly earnings data on Wednesday, June, 12th. The company reported ($3.00) earnings per share for the quarter, topping analysts' consensus estimates of ($4.00) by $1.00.

Shares of SUMM stock and other U.K. stocks can be purchased through online brokerage accounts that support trading on the London Stock Exchange (LSX). Some U.K. companies can be purchased through major U.S. brokerages in the form of American Depository Receipts (ADRs), which are placeholder equities held in a trust by a bank that represent shares of a foreign stock.

Based on aggregate information from My MarketBeat watchlists, some other companies that Summit Therapeutics investors own include Summit Therapeutics (SMMT), American Airlines Group (AAL), Acadia Healthcare (ACHC), Academy Sports and Outdoors (ASO), Diana Shipping (DSX), 2570 (JLF.L) (JLF) and National Fuel Gas (NFG).

Company Calendar

Last Earnings
6/12/2019
Today
7/15/2025

Industry, Sector and Symbol

Stock Exchange
LON
Sector
Medical
Industry
Drugs - Generic
Sub-Industry
N/A
Current Symbol
LON:SUMM
CIK
N/A
Fax
N/A
Employees
N/A
Year Founded
N/A

Profitability

EPS (Trailing Twelve Months)
N/A
Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
N/A
Net Margins
N/A
Pretax Margin
N/A
Return on Equity
N/A
Return on Assets
N/A

Debt

Debt-to-Equity Ratio
N/A
Current Ratio
N/A
Quick Ratio
N/A

Sales & Book Value

Annual Sales
N/A
Price / Sales
N/A
Cash Flow
N/A
Price / Cash Flow
N/A
Book Value
N/A
Price / Book
N/A

Miscellaneous

Outstanding Shares
N/A
Free Float
N/A
Market Cap
N/A
Optionable
Not Optionable
Beta
N/A
A Guide To High-Short-Interest Stocks Cover

MarketBeat's analysts have just released their top five short plays for July 2025. Learn which stocks have the most short interest and how to trade them. Enter your email address to see which companies made the list.

Get This Free Report

This page (LON:SUMM) was last updated on 7/15/2025 by MarketBeat.com Staff
From Our Partners